Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy

Medicina (Kaunas). 2022 Jul 21;58(7):967. doi: 10.3390/medicina58070967.

Abstract

Background and Objectives: Long-term hydroxychloroquine (HCQ) therapy can lead to retinal toxicity. Typically, it is characterized by a bull's eye maculopathy. More recently, a "pericentral" form of HCQ retinopathy that predominantly affects patients of Asian descent has been described. To our knowledge, this is the first reported case where such an asymmetry between the right and the left eye in the toxicity profile is observed. Case presentation: The patient presented with a 12-year exposure to HCQ at a daily dose of 4.35 mg/kg. She presented an inferior pericentral-only phenotype of HCQ toxicity on the right eye and a perifoveal-only toxicity on the left eye. Modest progression of toxicity was observed on both eyes over the seven years of follow-up, despite drug discontinuation. Conclusions: To our knowledge, this is the first time that two different phenotypes of HCQ-related retinopathy are found in the same patient, challenging our understanding of the pathophysiology of HCQ retinal toxicity.

Keywords: bull’s eye maculopathy; hydroxychloroquine; hydroxychloroquine toxicity screening; parafoveal retinal hydroxychloroquine toxicity; pericentral retinal hydroxychloroquine toxicity.

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents* / toxicity
  • Female
  • Humans
  • Hydroxychloroquine / adverse effects
  • Macular Degeneration*
  • Retinal Diseases* / chemically induced
  • Retinal Diseases* / drug therapy
  • Tomography, Optical Coherence

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine